The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.

Fan Gao, Tao Liu, Miao Tuo, Song Chi

Neuroscience letters 2021 Nov 20

filter terms:

Accumulating evidence has shown that sleep disturbance is a common symptom in Alzheimer's disease (AD), which is regarded as a modifiable risk factor for AD. Orexin is a key modulator of the sleep-wake cycle and has been found to be dysregulated in AD patients. The increased orexin in cerebrospinal fluid (CSF) is associated with decreased sleep efficiency and REM sleep, as well as cognitive impairment in AD patients. The orexin system has profuse projections to brain regions that are implicated in arousal and cognition and has been found to participate in the progression of AD pathology. Conversely the orexin receptor antagonists are able to consolidate sleep and reduce AD pathology. Therefore, improved understanding of the mechanisms linking orexin system, sleep disturbance and AD could make orexin receptor antagonists a promising target for the prevention or treatment of AD. Copyright © 2021 Elsevier B.V. All rights reserved.

Citation

Fan Gao, Tao Liu, Miao Tuo, Song Chi. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target. Neuroscience letters. 2021 Nov 20;765:136247